HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 69 filers reported holding HARVARD BIOSCIENCE INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,700,328 | -17.1% | 613,837 | -23.4% | 0.50% | -18.5% |
| Q3 2022 | $2,051,000 | -28.9% | 801,259 | 0.0% | 0.62% | -23.6% |
| Q2 2022 | $2,885,000 | -5.8% | 801,259 | +62.5% | 0.81% | +17.8% |
| Q1 2022 | $3,063,000 | -11.9% | 493,202 | 0.0% | 0.68% | -3.3% |
| Q4 2021 | $3,477,000 | +50.9% | 493,202 | +49.4% | 0.71% | +110.4% |
| Q3 2021 | $2,304,000 | -19.7% | 330,083 | -4.1% | 0.34% | -18.4% |
| Q2 2021 | $2,868,000 | +660.7% | 344,239 | +178.8% | 0.41% | +390.5% |
| Q4 2019 | $377,000 | -0.8% | 123,470 | 0.0% | 0.08% | +47.4% |
| Q3 2019 | $380,000 | +74.3% | 123,470 | +13.4% | 0.06% | +83.9% |
| Q2 2019 | $218,000 | -53.5% | 108,840 | 0.0% | 0.03% | -56.3% |
| Q1 2019 | $469,000 | – | 108,840 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harvey Partners, LLC | 790,000 | $2,378,000 | 3.09% |
| Alambic Investment Management, L.P. | 25,398 | $76,000 | 0.83% |
| Adirondack Research & Management Inc. | 190,494 | $573,000 | 0.80% |
| Archon Capital Management LLC | 881,794 | $2,654,000 | 0.53% |
| BARD ASSOCIATES INC | 1,483,610 | $4,465,000 | 0.47% |
| DALTON GREINER HARTMAN MAHER & CO | 909,977 | $2,739,000 | 0.45% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,537,800 | $4,629,000 | 0.40% |
| Portolan Capital Management | 979,067 | $2,947,000 | 0.33% |
| HEARTLAND ADVISORS INC | 961,400 | $2,894,000 | 0.25% |
| Granahan Investment Management | 1,757,176 | $5,289,000 | 0.18% |